COVID-19 and Obstetric Management

A special issue of Reports (ISSN 2571-841X).

Deadline for manuscript submissions: closed (30 April 2023) | Viewed by 2277

Special Issue Editor


E-Mail Website
Guest Editor
Department of Obstetrics and Gynecology, Kyushu University Hospital, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
Interests: epigenetics; DNA demethylation; ubiquitin ligase; gynecologic oncology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The outbreak of SARS-CoV2 and its variants has spread rapidly and impacted all of our lives. We have since acquired a lot of knowledge about COVID-19 after two year of the pandemic; however, we still need more information about COVID-19’s impact on maternal and newborn health outcomes. There is no doubt that we need to pay attention to various problems specific to pregnant women, fetuses, and newborn infants in the obstetrics field. In this Special Issue, we would like to publish a variety of research on aspects of COVID-19 related to the perinatal period, and we hope that this will be helpful to mothers and infants, in addition to all medical workers, including obstetricians, in the world.

The main topics of the Special Issue include, but are not limited to:

  1. The management of serious cases of COVID-19 in pregnant women; ECMO in utero or after termination.
  2. Prevention and treatment of thrombosis in pregnancy.
  3. The development of infants born from mothers with chronic severe hypoxia caused by COVID-19.
  4. The impact of new COVID-19 variants.
  5. The effects of new agent use on fetuses.

Dr. Ichiro Onoyama
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reports is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ECMO
  • thrombosis
  • infant development
  • hypoxia
  • variants
  • new agent
  • COVID-19

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 464 KiB  
Article
Evaluation of the Obstetric Patient: Pregnancy Outcomes during COVID-19 Pandemic—A Single-Center Retrospective Study in Romania
by Melinda Ildiko Mitranovici, Diana Maria Chiorean, Ioan Emilian Oală, Izabella Petre and Ovidiu Simion Cotoi
Reports 2022, 5(3), 27; https://doi.org/10.3390/reports5030027 - 11 Jul 2022
Cited by 1 | Viewed by 1859
Abstract
Acute respiratory-syndrome-related coronavirus 2, or SARS-CoV-2, has become a public health issue in our country. It mainly affects the vulnerable population, especially those with comorbidities. In this retrospective study, we set out to explore the effects of COVID-19 on pregnancy, with the vulnerability [...] Read more.
Acute respiratory-syndrome-related coronavirus 2, or SARS-CoV-2, has become a public health issue in our country. It mainly affects the vulnerable population, especially those with comorbidities. In this retrospective study, we set out to explore the effects of COVID-19 on pregnancy, with the vulnerability of pregnant women to SARS-CoV-2 infection also representing a main focus. We included 39 patients who tested positive for SARS-CoV-2 and 39 control subjects recruited from the Emergency County Hospital of Hunedoara, Romania. Our aim was to explore the indirect impact of the COVID-19 pandemic on pregnancy, as our patient group was included in the “high-risk” category. As a result, cesarean section prevailed, the main reason being fetal hypoxia. Newborns were evaluated by real-time postnatal polymerase chain reaction (RT-PCR) viral testing: none exhibited SARS-CoV-2 infection, with no vertical transmission of the virus being detected. Moreover, we observed no maternal or neonatal deaths resulting from COVID-19. SARS-CoV-2 has been found to cause a heterogeneity of manifestations with damage to multiple organs, and its evolution remains unknown. In our study, the need for antiviral treatment was limited, but anticoagulants proved effective in terms of improving the outcome. Full article
(This article belongs to the Special Issue COVID-19 and Obstetric Management)
Show Figures

Figure 1

Back to TopTop